Initial Treatonic FUNGAL NAIL RENEWAL PATCHES

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Initial Treatonic FUNGAL NAIL RENEWAL PATCHES
Generic name: TOLNAFTATE 1%
Manufacturer: 100 KARMA INC
Product type: HUMAN OTC DRUG
SPL set ID: 48e377b4-abb1-34cf-e063-6294a90a2ea3
SPL ID: 55b688c2-20f0-65fa-e063-6294a90afe1c
Version: 3
Effective date: 2026-07-03
Source export date: 2026-09-28
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:17:58

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Initial Treatonic FUNGAL NAIL RENEWAL PATCHES	openfda.brand_name
generic name		TOLNAFTATE 1%	openfda.generic_name
manufacturer name		100 KARMA INC	openfda.manufacturer_name
ndc	package	85569-013-01	openfda.package_ndc
ndc	product	85569-013	openfda.product_ndc
ndc11	package	85569001301	derived:openfda.package_ndc
rxcui		2677690	openfda.rxcui
spl id		55b688c2-20f0-65fa-e063-6294a90afe1c	id
spl set id		48e377b4-abb1-34cf-e063-6294a90a2ea3	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only on children under 2years of age unless directed lby a doctor on dliaper rash Avoid contact with eyes. do not exceed the recommended daily dosage unless directed by a doctor. iritation occurs there is no improvement within 4 weeks. ask a health professional before use. In case of accidental ingestion, seek medical advice immediately or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.